Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China

Gut

Volumn 57, Issue 12, 2008, Pages 1713-1720

  Zhang, H W ^a   Yin, J H ^a   Li, Y T ^b   Li, C Z ^a   Ren, H ^b   Gu, C Y ^a   Wu, H Y ^b   Liang, X S ^a   Zhang, P ^a   Zhao, J F ^a   Tan, X J ^a   Lu, W ^a   Schaefer, S ^c   Cao, G W ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHENZHEN CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN;

ACUTE HEPATITIS; ADULT; ARTICLE; CHINA; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE CARRIER; DISEASE COURSE; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VIRUS LOAD; VIRUS TRANSMISSION;

ACUTE DISEASE; ADULT; CASE-CONTROL STUDIES; CHINA; DISEASE PROGRESSION; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MULTIVARIATE ANALYSIS; PILOT PROJECTS; PREVALENCE; RISK FACTORS;

EID: 56549101144     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.157149     Document Type: Article

References (38)

1. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005;34(Suppl 1):S1-3.
2. Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 2004;38(10 Suppl):S158-68.
3. Hwang LY, Kramer JR, Troisi C, et al. Relationship of cosmetic procedures and drug use to hepatitis C and hepatitis B virus infections in a low-risk population. Hepatology 2006;44:341-51.
4. Fisker N, Pedersen C, Lange M, et al. Molecular epidemiology of hepatitis B virus infections in Denmark. J Clin Virol 2004;31:46-52.
5. Redd JT, Baumbach J, Kohn W, et al. Patient-to-patient transmission of hepatitis B virus associated with oral surgery. J Infect Dis 2007;195:1311-4.
6. Yao GB. Importance of perinatal versus horizontal transmission of hepatitis B virus infection in China. Gut 1996;38(Suppl 2):S39-42.
7. Thio CL, Thomas DL, Karacki P, et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 2003;77:12083-7.
8. Deng G, Zhou G, Zhai Y, et al. Association of estrogen receptor alpha polymorphisms with susceptibility to chronic hepatitis B virus infection. Hepatology 2004;40:318-26.
9. Chu CJ, Lok AS. Clinical significance of hepatitis B virus genotypes. Hepatology 2002;35:1274-6.
10. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine 2005;23:2409-23.
11. Schaefer S. Hepatitis B virus - significance of genotypes. J Viral Hepatol 2005;12:111-24.
12. Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology 2003;46:329-38.
13. Norder H, Couroucé AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004;47:289-309.
14. Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus genotypes. World J Gastroenterol 2007;13:14-21.
15. Yin J, Zhang H, Li C, et al. Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area. Carcinogenesis 2008;29:1685-91.
16. Mayerat C, Mantegani A, Frei PC. Does hepatitis B virus (HBV) genotype influence the clinical outcome of HBV infection? J Viral Hepatol 1999;6:299-304.
17. Wai CT, Fontana RJ, Poison J, et al. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepatol 2005;12:192-8.
18. Ozasa A, Tanaka Y, Orito E, et al. Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection. Hepatology 2006;44:326-34.
19. Barker LF, Chisari FV, McGrath PP, et al. Transmission of viral hepatitis type B to chimpanzees. J Infect Dis 1973;127:648- 62.
20. Cote PJ, Korba BE, Miller RH, et al. Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection. Hepatology 2000;31:190-200.
21. Fong TL, Di Bisceglie AM, Biswas R, et al. High levels of viral replication during acute hepatitis B infection predict progression to chronicity. J Med Virol 1994;43:155-8.
22. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45: 507-39.
23. Chen J, Yin J, Tan X, et al. Improved multiplex-PCR to identify HBV genotypes A-F and subgenotypes B1, B2 and C1, C2. J Clin Virol 2007;38:238-43.
24. Tamura K, Dudley J, Nei M, et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-9.
25. Chutanov VP, Shipulin GA, Schaefer S, et al. Kinetics of HBV DNA and HBsAg in acute hepatitis B patients with and without coinfection by other hepatitis viruses. J Med Virol 2003;69:313-23.
26. Johnson IL, Dwyer JJ, Rusen ID, et al. Survey of infection control procedures at manicure and pedicure establishments in North York. Can J Public Health 2001;92:134-7.
27. Lee DH, Kim JH, Nam JJ, et al. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci 2002;17:457-62.
28. Tassopoulos NC, Papaevangelou GJ, Sjogren MH, et al. Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults. Gastroenterology 1987;92:1844-50.
29. Beasley RP, Hwang LY, Lin CC, et al. Incidence of hepatitis among students at a university in Taiwan. Am J Epidemiol 1983;117:213-22.
30. McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis 1985;151:599-603.
31. Kaboth U, Adami B, Alexander M, et al. Cooperative prospective study "acute viral hepatitis" (In German). Verb Dtsch Ges Inn Med 1980;86:749-56.
32. Schomerus H, Wiedmann KH, Dolle W, et al. (+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial. Hepatology 1984;4:331-5.
33. Ding X, Mizokami M, Yao G, et al. Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China. Intervirology 2001;44:43-7.
34. Kidd-Ljunggren K, Holmberg A, Bläckberg J, et al. High levels of hepatitis B virus DNA in body fluids from chronic carriers. J Hosp Infect 2006;64:352-7.
35. Hui AY, Hung LC, Tse PC, et al. Transmission of hepatitis B by human bite - confirmation by detection of virus in saliva and full genome sequencing. J Clin Virol 2005;33:254-6.
36. Jettison SA, Lemon SM, Baker LN, et al. Quantitative analysis of hepatitis B virus DNA in saliva and semen of chronically infected homosexual men. J Infect Dis 1987;156:299-307.
37. Chen M, Sallberg M, Hughes J, et al. Immune tolerance split between hepatitis B vims precore and core proteins. J Virol 2005;79:3016-27.
38. Yuen MF, Wong DK Zheng BJ, et al. Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion. J Viral Hepatol 2007;14:269-75.